Skip to main content
Nihal El Rouby on Muck Rack

Nihal El Rouby

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nihal El

Contact Nihal El, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Global Investigation of Clinical Implementation Strategies for DPYD Testing to Guide Fluoropyrimidine Therapy

|
By Nihal El Rouby, Christina L. Aquilante, Larisa H Cavallari, Salma A. Bargal
| Wiley Online Library Verified
1 Introduction Fluoropyrimidines, which include intravenous 5-fluorouracil (5-FU) and its oral prodrugs capecitabine and tegafur, are a vital component of chemotherapy regimens to treat various cancer types, with an estimated 2 million patients worldwide receiving a fluoropyrimidine each year [1, 2].
Open in Who Shared Issue with article?

Multi‐Gene Pharmacogenomic Testing in a Community‐Based Setting Is Feasible and Reduces Total Healthcare Costs

|
By Nihal El Rouby, Josiah D Allen, Tyler Koep, Pat McIntyre
| Wiley Online Library Verified
What is the current knowledge on the topic? ○ Pharmacogenomic (PGx) testing using multigene panels has been shown to improve drug-related outcomes. However, data on its impact on economic outcomes remain limited. What question does this study address? ○ This study evaluates the prevalence of polypharmacy involving medications with pharmacogenetic guidance in a Medicare population within a primary care setting.
Open in Who Shared Issue with article?

Multi‐Gene Pharmacogenomic Testing in a Community‐Based Setting Is Feasible and Reduces Total Healthcare Costs

|
By Nihal El Rouby, Josiah D Allen, Tyler Koep, Pat McIntyre
| Wiley Online Library Verified
What is the current knowledge on the topic? ○ Pharmacogenomic (PGx) testing using multigene panels has been shown to improve drug-related outcomes. However, data on its impact on economic outcomes remain limited. What question does this study address? ○ This study evaluates the prevalence of polypharmacy involving medications with pharmacogenetic guidance in a Medicare population within a primary care setting.
Open in Who Shared Issue with article?
See all 6 articles